Gilead Sciences, Inc. (GILD)
Chart Events
Performance Outlook
| Previous Close | 64.95 |
| Open | 64.64 |
| Bid | 65.00 x 1200 |
| Ask | 65.01 x 1000 |
| Day's Range | 64.00 - 65.10 |
| 52 Week Range | 57.17 - 74.12 |
| Volume | |
| Avg. Volume | 6,934,000 |
| Market Cap | 81.463B |
| Beta (5Y Monthly) | 0.33 |
| PE Ratio (TTM) | 19.88 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.92 (4.50%) |
| Ex-Dividend Date | Sep 14, 2022 |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for GILD
Related Research
- Gilead Sciences, Inc.Analyst Report: Gilead Sciences, Inc.Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.RatingFair ValueEconomic Moat18 days agoMorningstar
- Insider Monkey
Top 20 Drug Companies in the World in 2022
In this article, we will be taking a look at the top 20 drug companies in the world in 2022. To skip our detailed analysis, you can go directly to see the top 5 drug companies in the world in 2022. While major pharmaceutical companies have always been derided for considering profits over the well-being […]
- Simply Wall St.
Gilead Sciences, Inc. (NASDAQ:GILD) Looks Just Right
With a price-to-earnings (or "P/E") ratio of 19.8x Gilead Sciences, Inc. ( NASDAQ:GILD ) may be sending bearish signals...
- Insider Monkey
10 Healthcare Stocks to Watch in Light of Biden’s ‘60 Minutes’ Interview
In this article, we will be taking a look at the 10 healthcare stocks to watch in light of Biden’s 60 Minutes interview. To skip our detailed analysis of these stocks and Biden’s insights, you can go directly to see the 5 Healthcare Stocks to Watch in Light of Biden’s 60 Minutes Interview. On September […]
